Clinical Study

Randomized Phase III Clinical Trial Of Adjuvant Radiation Versus Chemoradiation In Intermediate Risk, Stage I/IIa Cervical Cancer Treated With Initial Radical Hysterectomy And Pelvic Lymphadenectomy

Posted Date: May 22, 2020

  • Investigator: Thomas Herzog
  • Specialties: Cancer, Cervical Cancer, Oncology
  • Type of Study: Drug

The goal of this study is to determine if post-operative adjuvant chemo-radiation therapy (CRT) can significantly improve recurrence-free survival (RFS) when compared to radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy


To Be Eligible: Must Have Primary Cervical Cancer I-Iia, Adequate Organ Function, Gog Performance Status 0-2, No Severe Infection, No Previous Rt Or Chemo For Study Cancer, No Prior Malignancy Within 5 Years


Cervical Cancer, Chemoradiation

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.